BSEOthers1 Sept 2026 · 1 Sept 2026, 05:34 pm
Notice of Annual General Meeting and Annual Report
Nath Bio-Genes (India) Ltd · 537291
✦ AI SummaryResults
Nath Bio-Genes (India) Ltd has submitted its Notice of Annual General Meeting and Annual Report for the financial year 2025-26, including the adoption of financial statements, declaration of dividend, and re-appointment of a director.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Nath Bio-Genes (India) Ltd - 537291 - Reg. 34 (1) Annual Report.
Attachments (1)
📄pdf
Download →
e1e66c58-1dd0-49b5-9245-2344d5869667.pdf
View document text
01st September 2026
The Manager-Listing The Manager- Listing
BSE Limited National Stock Exchange of India Ltd.,
Phiroze Jeejeeb hoy Towers, Exchange Plaza, Bandra-Kurla Complex
Dalal Street, Bandra (E)
Mumbai-400001 Mumbai-400051
BSE Code- 537291 NSE Code-NATHBIOGEN
Sub: Submission of Notice of Annual General Meeting and Annual Report for the financial year 2025-
Ref: Regulation 34 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
Dear Sir/Madam,
With reference to the captioned subject, we are submitting herewith the Notice of the 33rd Annual
General Meeting (AGM) of the Company along with the Integrated Annual Report of the Company for
the financial year 2025-26, which is being sent to the shareholders by electronic mode.
The 33rd Annual General Meeting of the Company will be held on Thursday, 24th September 2026 at
11.00 a.m. through Video Conferencing/Other Audio Visual Means (VC/OAVM).
Pursuant to Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management
and Administration) Rules, 2014 and Regulation 44 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, the Company is pleased to provide its Members with the remote e-
voting facility to cast their votes electronically on the resolutions mentioned in the AGM Notice using
the electronic voting platform provided by National Securities Depository Limited (NSDL). The voting
rights of Members shall be in proportion to the shares held by them, as on the cut-off date i.e. Friday,
11th September 2026.
The remote e-voting period commences on Monday, 21st September 2026 at 9.00 a.m. and ends on
Wednesday, 23rd September 2026 at 5.00 p.m. The remote e-voting module shall be disabled by NSDL
for voting thereafter. In addition, the facility for voting through electronic voting system shall also be
made available at the AGM and the Members participating in the AGM through VC/OAVM, who have
not already cast their vote by remote e-voting, shall be able to exercise their voting rights in the meeting.
Kindly take the same on your record.
Please take the above on record and oblige.
Thanking you,
Yours faithfully,
For Nath Bio-Genes (India) Limited
Amol Arunrao Digitally signed by
Amol Arunrao Gupta
Gupta Date: 2026.09.01
16:18:43 +05'30'
Amol Gupta
Chief Financial Officer
33 ANNUAL REPORT
2025-26
CORPORATE INFORMATION
Directors
Mr. Sa(cid:415)sh Kagliwal - Managing Director
Mrs. Jeevanlata Kagliwal
Mr. Akash Kagliwal
Mr. Hitesh Purohit
Mr. Vadla Nagabhushanam
Mr. Madhukar Deshpande
Ms. Payal Jain
Chief Financial O(cid:312)cer
Mr. Amol Gupta
Company Secretary
Mr. Dhiraj Rathi
Statutory Auditors
Gautam N Associates
Chartered Accountant
30, GNA House, Behind ABC Complex,
Manmandir Travels Lane, Adalat Road,
Aurangabad-431 001
Bankers
1. Axis Bank
2. Janakalyan Sahakari Bank Ltd.
3. HDFC Bank Ltd.
4. State Bank of India.
Registered O(cid:312)ce
Nath House, Nath Road, Chh. Sambhajinagar-431005
0240-6645555
Corporate O(cid:312)ce
1, Chateau Windsor
86, Veer Nariman Road
Churchgate, Mumbai – 400 020
Registrar & Transfer Agents
Big Share Service Private Limited,
O(cid:312)ce NoS6-2, 6th Floor, Pinnacle Business Park,
Next to Ahura Center, Mahakali caves Road,
Andheri East, Mumbai-400 059.
CONTENTS
Sr. No. No(cid:415)ce Page No.
1 No(cid:415)ce of Annual General Mee(cid:415)ng 1
2 Managing Director’s Statement 20
3 Director’s Report 22
4 Management Discussion & Analysis Report 56
5 Corporate Governance Report 66
6 Independent Auditor’s Report (Standalone) 100
7 Financial Statement (Standalone) 112
8 Independent Auditor’s Report (Consolidated) 142
9 Financial Statement (Consolidated) 150
NOTICE OF ANNUAL GENERAL MEETING
Notice is hereby given that the thirty-three annual general meeting of Nath bio-genes (India) Limited
will be held on Thursday, 24th September 2026 at 11.00 a.m. IST through video conferencing (vc)/
other means (oavm) to transact the following business:
ORDINARY BUSINESS.
1. ADOPTION OF FINANCIAL STATEMENTS.
To receive, consider and adopt the Audited Balance Sheet of the Company as of March 31, 2026,
and Statement of Profit & Loss for the year ended as on that date together with the Reports of
Directors and Auditors thereon.
To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:
“RESOLVED THAT the audited Standalone Financial Statement of the Company for the financial
year ended 31st March, 2026, together with the Reports of the Board of Directors and the
Statutory Auditor thereon, be and are hereby received, considered and adopted.”
“RESOLVED THAT the audited Consolidated Financial Statement of the Company for the financial
year ended 31st March, 2026, together with the Report of the Statutory Auditor thereon, be and
are hereby received, considered and adopted.”
2. DECLARATION OF DIVIDEND.
To declare a final Dividend of ₹ 2 per equity shares of face value of ₹ 10 each for financial year
ended 31st March 2026.
To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:
“RESOLVED THAT as recommended by the Board of Directors, dividend for the financial year 2025-
26 at the rate of ₹ 2 per equity shares of face value of ₹ 10 each, be and is hereby declared and
that the said dividend be paid out of the profits of the Company to the eligible equity
shareholders.”
3. RE-APPOINTMENT OF DIRECTOR RETIRING BY ROTATION.
To appoint Mrs. Jeevanlata Kagliwal (DIN-02057459) as Director of the Company, who retires by
rotation and being eligible, offer herself for re-appointment.
To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution
RESOLVED THAT in accordance with the provisions of Section 152 and other applicable provisions,
if any, of the Companies Act, 2013, including any statutory modification(s) or re-enactment
thereof for the time being in force, Mrs. Jeevanlata Kagliwal (DIN: 02057459), who retires as a
Director by rotation and, being eligible, has offered herself for re appointment, be and is hereby
re-appointed as a Director of the Company.”
11 // 118821
SPECIAL BUSINESS
4. RE-APPOINTMENT OF MR. HITESH RAJNIKANT PUROHIT AS INDEPENDENT DIRECTOR OF THE
COMPANY
To consider, and if thought fit, to pass the following resolution as a Special Resolution:
“RESOLVED THAT pursuant to the provisions of Sections 149, 150, 152 and other applicable provisions
of the Companies Act, 2013, the Companies (Appointment and Qualification of Directors) Rules, 2014
read with Schedule IV to the Companies Act, 2013 and Regulation 16(1)(b), 17, 25 and other applicable
provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) thereof)
and the provisions of the Articles of Association of the Company, and based on the performance
evaluation, recommendation of the Nomination and Remuneration Committee and approval of the
Board of Directors at their respective Meeting held on 04th May, 2026, Mr. Hitesh Rajnikant Purohit
(DIN: 02340858), who has submitted a declaration that he meets the criteria of independence as
provided under Section 149(6) of the Companies Act, 2013 and the Rules made thereunder and
Regulation 16(1)(b) of the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015 and is eligible for re-appointment, and in respect of whom the
Company has received a notice in writing under Section 160 of the Companies Act, 2013 proposing his
candidature for the office of Independent Director, be and is hereby re-appointed as an Independent
Director of the Company for a second term of five consecutive years with effect from 30th March, 2027
to 29th March, 2032, and that he shall not be liable to retire by rotation.
RESOLVED FURTHER THAT the Board of Directors of the Company be and is hereby authorized to do
all such acts, deeds, matters and things and execute all such document
[Showing first 8,000 characters — download PDF for full document]